Keywords = HCV
| Number of Articles: 238 | ||||
| 51 | EVALUATION OF THE SAFETY AND RESISTANCE ASSOCIATED VARIANTS OF SOFOSBUVIR/DACLATASVIR AMONG EGYPTIAN PATIENTS WITH HEPATITIS C VIRUS: A PROSPECTIVE STUDY | |||
| Volume 45, Issue 2, December 2022, Page 1143-1153 | ||||
| Haidi Karam -Allah Ramadan; , Soha Saoud Abdel-Monem; Ahlam Mohamed Ahmed; Rasha Maree Omar; Hala Rady Ahmed; Helal F. Hetta | ||||
| 52 | Deciphering The Correlation Between Triclosan and Immune Response to HCV Infection | |||
| Volume 14, Issue 2, December 2022, Page 143-157 | ||||
| Mohamed H. Mohamed; Hosni A. M. Hussein; Magdy M. Afifi; Elsayed K. Bakhiet; Serageldeen Sultan | ||||
| 53 | N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE IN HEPATITIS C VIRUS MAINTENANCE HEMODIALYSIS PATIENTS AND ITS RELATION TO DIASTOLIC DYSFUNCTION AND CHILD PUGH SCORE | |||
| Volume 4, Issue 4, December 2022, Page 36-37 | ||||
| Sherif Aziz Zaki; Hesham Abdallah Elghoneimy; Mostafa Elwany; Amr Wahid Labib | ||||
| 54 | Impact of Sofosbuvir and Daclatasvir therapy on the expression levels of inflammasomes in chronic hepatitis C infected patients | |||
| Volume 3, Issue 4, November 2022, Page 890-898 | ||||
| aya fergany; Helal Hetta; Khaled Hassanein; Mohammed medhat; Gaber batiha; Asmaa S. Shaltout | ||||
| 55 | The Link between an Epidermal Growth Factor Gene Functional Polymorphism and Hepatocellular Carcinoma in a Cohort of Hepatitis C Egyptian Patients | |||
| Volume 89, Issue 1, October 2022, Page 5860-5864 | ||||
| Bothaina A. Madkour; Ola M. Mahmoud; Ola B Abo El Nil; Mohamed A. Aboul-Ezz; Shereif A. Morsy; Ahmed R. Mashaal; Omar M. Sabry | ||||
| 56 | Lymphoid Malignancies and Direct-Acting Antivirals: Review Article | |||
| Volume 89, Issue 1, October 2022, Page 4540-4543 | ||||
| walaa gamal soliman; Amr Mohamed Zaghloul; Ali Mohammed Ali; Mohamed Soliman Gaber | ||||
| 57 | Combined Sofosbuvir/Daclatasvir and Chemotherapy Markedly Improve The Outcome of B-Lymphoid Malignancies in Patients with Both HCV Infection and B-Lymphoid Malignancy | |||
| Volume 89, Issue 1, October 2022, Page 4676-4684 | ||||
| walaa gamal soliman; Amr Mohamed Zaghloul; Ali Mohammed Ali; Mohamed Soliman Gaber | ||||
| 58 | Hepatocellular Carcinoma Post Direct Anti Hepatitis C Viral Agents; Clinical Features | |||
| Volume 5, Issue 2, October 2022, Page 5-15 | ||||
| Nabila H Ahmed; Amira Elwan; Essam Adel Abdelrahman; Ahmed Embaby; Ahmed S Mohammed | ||||
| 59 | Genetic polymorphism in IL-28 B and LMP-7 genes: Role in HCV-induced Hepatocellular Carcinoma | |||
| Volume 31, Issue 4, October 2022, Page 107-111 | ||||
| Noha Saad Elmekawy; Sahar T. Mohamed; Sanaa Mohei El-dein; Mona M. Arafa; Noha T. Abou El-Khier | ||||
| 60 | Effect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients | |||
| Volume 10, Issue 4, October 2022, Page 219-224 | ||||
| 61 | Assessment of Serum Fetuin A level in Patients with NAFLD and Chronic Hepatitis C | |||
| Volume 89, Issue 2, October 2022, Page 6282-6288 | ||||
| Mohamed Ali Awadein; Mohamed Ali Marie Makholof; Shereen Abo Bakr Saleh; Mohamed Magdy Salama; Roqaya Mohamed Hussein; Amira R. El-Ansary | ||||
| 62 | HLA DRB1 Alleles in Association with Chronic Hepatitis C Virus Infection and Autoimmune Hepatitis | |||
| Volume 31, Issue 4, October 2022, Page 93-101 | ||||
| Amira Shalaa; Mona Morsi; Mohamed Abd elrahman Ahmed; Khalid Al Zaafarany; Shams Abd elfattah Arafa | ||||
| 63 | Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone] | |||
| Volume 7, Issue 3, September 2022, Page 167-173 | ||||
| Aly Abdou; Hassan M. Mostafa; Abdel-Mawgoud M. Abdel-Mawgoud | ||||
| 64 | The Possible Histological Effects of Daclatasvir on Liver Cells of the Pregnant Mice | |||
| Volume 45, Issue 3, September 2022, Page 687-702 | ||||
| Mennat Allah Saqr; Hoda Saleib; Nader Elnemr; Hoda Mahmoud Khalifa; Nancy El Sekily | ||||
| 65 | Interference between miR-21/PTEN/E-Cadherin and Epithelial-Mesenchymal Transition in Various Stages of Chronic HCV Infection | |||
| Volume 8, Issue 3, September 2022, Page 221-235 | ||||
| Yasser B.M. Ali; Mohamed G. Thabet; Abeer M. El-Maghraby; Asmaa Gomaa; Omaima A. Khamiss; Roba M. Talaat | ||||
| 66 | EVALUATION OF THE IMPACT OF HLA-G 14BP POLYMORPHISM ON THE SUSCEPTIBILITY OF HEPATITIS C VIRUS INFECTION IN EGYPTIAN PATIENTS | |||
| Volume 51, Issue 4, August 2022, Page 2091-2098 | ||||
| Ashraf Mohamed Deiaa El-Din Mohamed; Abd El-Moneim Mohamed Hosny; Ibrahim Metwaly Bayomy; Mahmoud Haddad Hemeda | ||||
| 67 | The Frequency of Hepatitis C Viral Infections and its Correlation with IL-12 and IL-18 among Major Thalassemic Patients in Baghdad | |||
| Volume 65, Issue 8, August 2022, Page 593-600 | ||||
| Rana Akram Hadi; Zainab A. Hamid | ||||
| 68 | Is the Treatment with Direct Acting Antiviral Agents (DAAs) Affecting Glomerular Filtration Rate (GFR)? | |||
| Volume 88, Issue 1, July 2022, Page 2417-2421 | ||||
| Iman Ibrahem Sarhan; Reem Mohsen Elsharabasy; Mohamed Hassan Abdel Gawad Mohamed; Fatma Abdelrahman Ahmed | ||||
| 69 | Comparative Study between Responders and Non Responders Among Patients Treated for Hepatitis C virus Infection | |||
| Volume 39, Issue 2, July and August 2022, Page 589-601 | ||||
| Amr Elhammadi; Dina Ziada; Wael Farrag | ||||
| 70 | COBALAMIN (VITAMIN B12) AS A TUMOR MARKER FOR DETECTION OF HCC AMONG EGYPTIAN PATIENTS WITH POST HEPATITIC CIRRHOSIS | |||
| Volume 51, Issue 3, July 2022, Page 1737-1750 | ||||
| Mustafa Muhammed Hasan; Khaled Massoud Dessouky; Mahmod Osama Ahmed Abd EL-Fattah; Hossam El-Sayed Abd-allah El-Ashmawy | ||||
| 71 | EVALUATION OF DIFFERENT ELASTOGRAPHY TECHNIQUES IN PREDICTION OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS C RELATED LIVER CIRRHOSIS | |||
| Volume 51, Issue 3, July 2022, Page 1655-1666 | ||||
| Ahmed Helal; Magdy Al-Dahshan; Mohamed Hassany; Ayman Hassan; Ahmed Eliwa; Ahmed Al-Wassief; Mohamed Al-Boraie | ||||
| 72 | During the Era of Pandemic Corona Virus Disease 19, is Telemedicine Effective in the follow-up of Hepatitis C Virus Patients Receiving Direct anti-Viral Therapy? | |||
| Volume 12, Issue 2, June 2022, Page 157-162 | ||||
| Alshymaa A Hassnine; Yasser M Foaud; Taha M Hassanin; Hatem A Hassan; Abbas M Abbas; Amr M Elsayed | ||||
| 73 | Pattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients | |||
| Volume 87, Issue 1, April 2022, Page 2057-2063 | ||||
| Reem M. Abd El Hamed; Ghada M. Galal; Nagwa S. Ahmed; Mahmoud Saif Al-Islam | ||||
| 74 | Safety and Efficacy of Direct Acting Antivirals for Hepatitis C Virus Infection in Thalassemic Patients and Its Effect on Transfusion Requirements | |||
| Volume 87, Issue 1, April 2022, Page 1975-1981 | ||||
| Gina Gamal Naguib; Maha Abd El-Aziz Eltouny; Ossama Ashraf Ahmed; Iman Ahmed Ragab; Shereen Abdel-Monem Ibrahim; Sherif Ahmed Megahed Ahmed; Walaa M. Hashem | ||||
| 75 | Comparative Study of SIRT1 Expression in Hepatitis B Virus, Hepatitis C Virus, and Hepatocellular Carcinoma Patients | |||
| Volume 3, Issue 2, April 2022, Page 170-184 | ||||
| Ahmed Amin Ibrahim; Laila Ahmed Rashed; Antoun K.S. Ghaly; Mohamed Ragab Ahmed | ||||
| | ||||
View on SCiNiTO
